Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganmaoqing Capsules is a combination pharmaceutical and herbal product used in Traditional Chinese Medicine (TCM) for the treatment of the common cold and influenza. The formulation typically integrates Western active ingredients, including paracetamol (acetaminophen) for antipyretic and analgesic effects, chlorpheniramine maleate as an antihistamine to relieve nasal congestion, and moroxydine hydrochloride for antiviral activity. These are combined with herbal extracts such as *Ilex asprella* (Gang Mei), *Isatis indigotica* (Nan Ban Lan Gen), and *Chrysanthemum indicum* (Ye Ju Hua), which are traditionally utilized for their anti-inflammatory and heat-clearing properties. The product is manufactured by several companies in China, including Jiangxi Hengkang Pharmaceutical, and is indicated for the relief of symptoms such as fever, headache, sore throat, and nasal discharge associated with respiratory infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ganmaoqing Capsules.